iX Biopharma Ltd. (SG:42C) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
iX Biopharma Ltd has announced a reduction in net proceeds from its Rights cum Warrants Issue to $1.55 million after a significant shareholder, Anson Properties, was unable to fulfill its subscription commitment due to timing of funds. Anson Properties still intends to invest in the company within the next four to six weeks. The company reassures that this event will not materially impact operations or finances and will keep the market updated through SGXNET.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.